118 related articles for article (PubMed ID: 15720410)
1. Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology.
Leoncini L; Delsol G; Gascoyne RD; Harris NL; Pileri SA; Piris MA; Stein H
Histopathology; 2005 Mar; 46(3):241-55. PubMed ID: 15720410
[TBL] [Abstract][Full Text] [Related]
2. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
3. Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.
Campo E; Chott A; Kinney MC; Leoncini L; Meijer CJ; Papadimitriou CS; Piris MA; Stein H; Swerdlow SH
Histopathology; 2006 Apr; 48(5):481-504. PubMed ID: 16623775
[TBL] [Abstract][Full Text] [Related]
4. [Classification of lymphomas].
Molina T; Diebold J; Audouin J
Rev Prat; 2002 May; 52(9):951-8. PubMed ID: 12063760
[TBL] [Abstract][Full Text] [Related]
5. Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation.
Lin P; Molina TJ; Cook JR; Swerdlow SH
Am J Clin Pathol; 2011 Aug; 136(2):195-210. PubMed ID: 21757593
[TBL] [Abstract][Full Text] [Related]
6. Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.
Quintanilla-Martinez L; de Jong D; de Mascarel A; Hsi ED; Kluin P; Natkunam Y; Parrens M; Pileri S; Ott G
J Hematop; 2009 Dec; 2(4):211-36. PubMed ID: 20309430
[TBL] [Abstract][Full Text] [Related]
7. Plasmablastic lymphoma and related disorders.
Hsi ED; Lorsbach RB; Fend F; Dogan A
Am J Clin Pathol; 2011 Aug; 136(2):183-94. PubMed ID: 21757592
[TBL] [Abstract][Full Text] [Related]
8. Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology.
Porwit A; Fend F; Kremer M; Orazi A; Safali M; van der Walt J
Histopathology; 2016 Sep; 69(3):349-73. PubMed ID: 27208429
[TBL] [Abstract][Full Text] [Related]
9. Aggressive B-cell lymphomas with a primary bone marrow presentation.
Zamò A; Johnston P; Attygalle AD; Laurent C; Arber DA; Fend F
Histopathology; 2020 Sep; 77(3):369-379. PubMed ID: 32324290
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.
Kinney MC; Jones D
Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828
[TBL] [Abstract][Full Text] [Related]
11. Are there site-specific differences among extranodal aggressive B-cell neoplasms?
Mann RB
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S144-50. PubMed ID: 9894479
[TBL] [Abstract][Full Text] [Related]
12. Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
Dotlic S; Gibson SE; Hartmann S; Hsi ED; Klimkowska M; Rodriguez-Pinilla SM; Sabattini E; Tousseyn TA; de Jong D; Dojcinov S
Virchows Arch; 2023 Nov; 483(5):591-609. PubMed ID: 37561194
[TBL] [Abstract][Full Text] [Related]
13. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.
Wada K; Maeda K; Tajima K; Kato T; Kobata T; Yamakawa M
Histopathology; 2009 Jan; 54(2):221-32. PubMed ID: 19207947
[TBL] [Abstract][Full Text] [Related]
14. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
[TBL] [Abstract][Full Text] [Related]
15. [Classification and differential diagnosis of B-cell lymphomas].
Anagnostopoulos I
Verh Dtsch Ges Pathol; 2003; 87():32-42. PubMed ID: 16888892
[TBL] [Abstract][Full Text] [Related]
16. The clinicopathologic spectrum of mature aggressive B cell lymphomas.
Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Facchetti F; Pileri S; Rosenwald A; Wotherspoon A; Fend F
Virchows Arch; 2017 Oct; 471(4):453-466. PubMed ID: 28844114
[TBL] [Abstract][Full Text] [Related]
17. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
Senff NJ; Willemze R
Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
[TBL] [Abstract][Full Text] [Related]
18. Nodal and splenic marginal zone B cell lymphomas.
Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
[TBL] [Abstract][Full Text] [Related]
19. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
20. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
